What the FDA labels say about taking them together
Isotretinoin and minocycline
Minocycline's FDA label of April 2, 2026 names isotretinoin in its drug interactions section; the isotretinoin labels PlainMeds reads (2) do not name minocycline. The minocycline label: “Avoid concomitant use of isotretinoin and EMROSI because isotretinoin, a systemic retinoid, is also known to cause idiopathic intracranial hypertension.”
Check it at the source: the isotretinoin FDA label on DailyMed (effective August 19, 2026, Sun Pharmaceutical Industries, Inc.); the minocycline FDA label on DailyMed (effective April 2, 2026, Torrent Pharmaceuticals Limited).
What does the isotretinoin label say about minocycline?
Isotretinoin's label (effective August 19, 2026) and its 1 other brand-application label do not name minocycline in these sections. A label lists what its studies and reports found; it is not a complete list.
Source: FDA drug label (Absorica LD), Sun Pharmaceutical Industries, Inc., effective August 19, 2026 (SPL set 3ef0cff8-19c1-4441-b780-fca6c7ee1615), via openFDA; the full label on DailyMed
What does the minocycline label say about isotretinoin?
Minocycline label, drug interactionsAdministration of isotretinoin should be avoided shortly before, during, and shortly after minocycline therapy.
Minocycline label, warningsConcomitant use of isotretinoin and minocycline hydrochloride should be avoided because isotretinoin is also known to cause pseudotumor cerebri.
Emrosi label (Journey Medical Corporation, April 22, 2025), warnings and precautionsAvoid concomitant use of isotretinoin and EMROSI because isotretinoin, a systemic retinoid, is also known to cause idiopathic intracranial hypertension.
Source: FDA drug label (Emrosi, NDA219015), Journey Medical Corporation, effective April 22, 2025 (SPL set 0899eb25-8807-037c-f66c-141a2696b1c0), via openFDA
Source: FDA drug label (Zilxi, NDA213690), Journey Medical Corporation, effective February 9, 2024 (SPL set cbffa96e-2446-43cf-ba5e-38c645302afd), via openFDA
Source: FDA drug label (Minocycline Hydrochloride), Torrent Pharmaceuticals Limited, effective April 2, 2026 (SPL set 55df55fb-18ec-4e00-9ed0-10bba0da513b), via openFDA; the full label on DailyMed
These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.
Both medicines on the record
| Isotretinoin | Minocycline | |
|---|---|---|
| Labeled for | Acne | Urinary tract infections |
| Boxed warning | Yes | No |
| Pharmacy cost (NADAC) | $11.94 per capsule 10 mg capsule | $0.343 per capsule 100 mg capsule |
| Shortage now | No current entry | No current entry |
Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Check more medicines together
- up to five at once